These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
709 related articles for article (PubMed ID: 11014575)
41. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113 [TBL] [Abstract][Full Text] [Related]
42. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions. Lonardi S; Manera C; Marucci R; Santoro A; Lorenzi L; Facchetti F Diagn Cytopathol; 2011 May; 39(5):313-7. PubMed ID: 21488172 [TBL] [Abstract][Full Text] [Related]
43. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Davidson B; Skrede M; Silins I; Shih IeM; Trope CG; Flørenes VA Cancer; 2007 Sep; 110(6):1264-71. PubMed ID: 17647260 [TBL] [Abstract][Full Text] [Related]
44. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B; Shih IeM; Wang TL Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238 [TBL] [Abstract][Full Text] [Related]
45. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies. Flynn MK; Johnston W; Bigner S Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236 [TBL] [Abstract][Full Text] [Related]
46. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899 [TBL] [Abstract][Full Text] [Related]
47. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions. Conner JR; Cibas ES; Hornick JL; Qian X Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters. Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818 [TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma. Imai J; Ghazizadeh M; Naito Z; Asano G Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208 [TBL] [Abstract][Full Text] [Related]
50. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861 [TBL] [Abstract][Full Text] [Related]
51. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938 [TBL] [Abstract][Full Text] [Related]
52. Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas. Freire T; Medeiros A; Reis CA; Real FX; Osinaga E Oncol Rep; 2003; 10(5):1577-85. PubMed ID: 12883744 [TBL] [Abstract][Full Text] [Related]
53. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070 [TBL] [Abstract][Full Text] [Related]
54. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Shield PW; Koivurinne K Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095 [TBL] [Abstract][Full Text] [Related]
55. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group]. Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400 [TBL] [Abstract][Full Text] [Related]
56. Immunoperoxidase staining of malignant cells in pleural effusions. Pastormerlo M Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143 [TBL] [Abstract][Full Text] [Related]
58. Cytological study of serous effusions with the aid of tumour markers. Ray K; Mittal S; Gupta H; Jain M J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179 [TBL] [Abstract][Full Text] [Related]
59. Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus. Ikeda Y; Kuwano H; Baba K; Ikebe M; Matushima T; Adachi Y; Mori M; Sugimachi K Cancer Res; 1993 Apr; 53(7):1706-8. PubMed ID: 8453646 [TBL] [Abstract][Full Text] [Related]
60. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein. Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]